KATP--fact or artefact? New thoughts on the mode of action of the potassium channel openers.
Edwards
G
G
School of Biological Sciences, University of Manchester, United Kingdom.
Weston
A H
AH
D000818:Animals; D001578:Benzopyrans / Q000378:metabolism; D019806:Cromakalim; D004594:Electrophysiology; D006146:Guanidines / Q000378:metabolism; D007340:Insulinoma / Q000378:metabolism; D015640:Ion Channel Gating / Q000502:physiology*; D009131:Muscle, Smooth, Vascular / Q000378:metabolism*; D010190:Pancreatic Neoplasms / Q000378:metabolism; D010766:Phosphorylation; D010847:Picolines / Q000378:metabolism; D015221:Potassium Channels / Q000502:physiology*; D011714:Pyrans / Q000378:metabolism; D011758:Pyrroles / Q000378:metabolism; D051381:Rats; D014407:Tumor Cells, Cultured / Q000378:metabolism; D014665:Vasodilator Agents / Q000378:metabolism*
D001578:Benzopyrans; D006146:Guanidines; D010847:Picolines; D015221:Potassium Channels; D011714:Pyrans; D011758:Pyrroles; D014665:Vasodilator Agents; D019806:Cromakalim; C061043:aprikalim; C058754:N'-cyano-N-(3-pyridyl)-N''-(t-butyl)guanidine